| Product Code: ETC12465486 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Immunotherapy Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Immunotherapy Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Immunotherapy Drugs Market - Industry Life Cycle |
3.4 India Immunotherapy Drugs Market - Porter's Five Forces |
3.5 India Immunotherapy Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 India Immunotherapy Drugs Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 India Immunotherapy Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 India Immunotherapy Drugs Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.9 India Immunotherapy Drugs Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
4 India Immunotherapy Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and other chronic diseases in India |
4.2.2 Growing awareness about the benefits of immunotherapy over traditional treatments |
4.2.3 Government initiatives to improve healthcare infrastructure and access to advanced treatments |
4.3 Market Restraints |
4.3.1 High cost associated with immunotherapy drugs |
4.3.2 Limited reimbursement policies for immunotherapy treatments in India |
4.3.3 Lack of skilled healthcare professionals trained in immunotherapy |
5 India Immunotherapy Drugs Market Trends |
6 India Immunotherapy Drugs Market, By Types |
6.1 India Immunotherapy Drugs Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 India Immunotherapy Drugs Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 India Immunotherapy Drugs Market Revenues & Volume, By Checkpoint Inhibitors, 2021 - 2031F |
6.1.4 India Immunotherapy Drugs Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.1.5 India Immunotherapy Drugs Market Revenues & Volume, By Cancer Vaccines, 2021 - 2031F |
6.1.6 India Immunotherapy Drugs Market Revenues & Volume, By Cytokines, 2021 - 2031F |
6.1.7 India Immunotherapy Drugs Market Revenues & Volume, By Adoptive T-Cell Therapy, 2021 - 2031F |
6.2 India Immunotherapy Drugs Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 India Immunotherapy Drugs Market Revenues & Volume, By Lung Cancer, 2021 - 2031F |
6.2.3 India Immunotherapy Drugs Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.2.4 India Immunotherapy Drugs Market Revenues & Volume, By Melanoma, 2021 - 2031F |
6.2.5 India Immunotherapy Drugs Market Revenues & Volume, By Leukemia, 2021 - 2031F |
6.2.6 India Immunotherapy Drugs Market Revenues & Volume, By Multiple Myeloma, 2021 - 2031F |
6.3 India Immunotherapy Drugs Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 India Immunotherapy Drugs Market Revenues & Volume, By Oncology Centers, 2021 - 2031F |
6.3.3 India Immunotherapy Drugs Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.4 India Immunotherapy Drugs Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 India Immunotherapy Drugs Market Revenues & Volume, By Research Institutions, 2021 - 2031F |
6.3.6 India Immunotherapy Drugs Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4 India Immunotherapy Drugs Market, By Mechanism of Action |
6.4.1 Overview and Analysis |
6.4.2 India Immunotherapy Drugs Market Revenues & Volume, By PD-1/PD-L1 Blocking, 2021 - 2031F |
6.4.3 India Immunotherapy Drugs Market Revenues & Volume, By Immune System Activation, 2021 - 2031F |
6.4.4 India Immunotherapy Drugs Market Revenues & Volume, By Tumor Cell Recognition, 2021 - 2031F |
6.4.5 India Immunotherapy Drugs Market Revenues & Volume, By Signal Pathway Modulation, 2021 - 2031F |
6.4.6 India Immunotherapy Drugs Market Revenues & Volume, By CAR-T Cell Therapy, 2021 - 2031F |
6.5 India Immunotherapy Drugs Market, By Sales Channel |
6.5.1 Overview and Analysis |
6.5.2 India Immunotherapy Drugs Market Revenues & Volume, By Direct Sales, 2021 - 2031F |
6.5.3 India Immunotherapy Drugs Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.5.4 India Immunotherapy Drugs Market Revenues & Volume, By Wholesale Suppliers, 2021 - 2031F |
6.5.5 India Immunotherapy Drugs Market Revenues & Volume, By Government Procurement, 2021 - 2031F |
6.5.6 India Immunotherapy Drugs Market Revenues & Volume, By Hospital Contracts, 2021 - 2031F |
7 India Immunotherapy Drugs Market Import-Export Trade Statistics |
7.1 India Immunotherapy Drugs Market Export to Major Countries |
7.2 India Immunotherapy Drugs Market Imports from Major Countries |
8 India Immunotherapy Drugs Market Key Performance Indicators |
8.1 Patient survival rates post-immunotherapy treatment |
8.2 Number of clinical trials for immunotherapy drugs conducted in India |
8.3 Adoption rate of immunotherapy treatments in different regions of India. |
9 India Immunotherapy Drugs Market - Opportunity Assessment |
9.1 India Immunotherapy Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 India Immunotherapy Drugs Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 India Immunotherapy Drugs Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 India Immunotherapy Drugs Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.5 India Immunotherapy Drugs Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
10 India Immunotherapy Drugs Market - Competitive Landscape |
10.1 India Immunotherapy Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Immunotherapy Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here